Abstract:
The present invention relates to novel primitive cell colony stimulating factors (PC-CSFs) and active fragments thereof, derived from non-adherent (NA) bone marrow cells. These factors are useful for treating disorders of the hematopoietic system. Antibodies directed against epitopes specific for PC-CSF can be used to purify PC-CSF, as well as for diagnosis of hematopoietic disorders.